The core targets identified in this study—TP53, AKT1, VEGFA, and IL6—play critical roles in the pathogenesis of AKI, involving inflammatory responses, apoptosis, angiogenesis, and signaling pathway regulation. The gene discussed is IL6; the disease is acute kidney injury.